Description

2,4-Dioxo-1,3,4,6,7,11B-Hexahydro-2H-Pyrido[2,1-A]Isoquinoline-3-Carbaldehyde o-Methyloxime is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused-ring structure. This compound matters as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting central nervous system (CNS) disorders. Pharmaceutical R&D laboratories and fine chemical manufacturers need this precise intermediate to develop next-generation therapeutic agents with improved efficacy and safety profiles.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the research and development of novel psychoactive substances and CNS-targeting drugs.
• Organic Synthesis Building Block: Utilized in complex multi-step organic syntheses to construct intricate nitrogen-containing heterocycles.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies in drug discovery programs.
• Reference Standard: Used as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Chemical Biology Probe: Employed in biochemical assays to study enzyme interactions and receptor binding mechanisms.

Basic Information

Item	Details
Product Name	2,4-Dioxo-1,3,4,6,7,11B-Hexahydro-2H-Pyrido[2,1-A]Isoquinoline-3-Carbaldehyde o-Methyloxime
CAS No.	338762-08-6
Molecular Formula	C15H16N2O3
Molecular Weight	272.30 g/mol
Synonyms	2,4-Dioxo-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline-3-carboxaldehyde O-methyloxime; 2H-Pyrido[2,1-a]isoquinoline-3-carboxaldehyde, 1,3,4,6,7,11b-hexahydro-2,4-dioxo-, O-methyloxime; 338762-08-6; Pyrido[2,1-a]isoquinoline derivative; 3-Carbaldehyde o-methyloxime derivative; Hexahydro-2H-pyrido[2,1-a]isoquinoline dione oxime
EINECS	Contact for details

Quality Control

Our 2,4-Dioxo-1,3,4,6,7,11B-Hexahydro-2H-Pyrido[2,1-A]Isoquinoline-3-Carbaldehyde o-Methyloxime is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure compliance with exacting standards for pharmaceutical intermediates. Certificates of Analysis (COA) with full traceability are provided to guarantee supply reliability and batch-to-batch consistency for your critical R&D and production processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and should be handled under an inert atmosphere for prolonged stability, especially after opening the primary container.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.